Addiction Treatment Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to addiction treatment market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Addiction Treatment Market News

 
  • In May 2023, Camurus AB, a Swedish science-driven biopharma company, announced that Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe opioid use disorder (OUD). 
  • On May 14, 2024, Lifespan Health System announced a new addiction treatment program aiming to provide same-day assistance to patients. It's called Addiction Care Today, and it aims to provide walk-in and same-day appointments to people seeking to start treatment for substance use disorders. 
  • In February 2024, Union Council of Ministers had announced that they had launched 41 dedicated addiction treatment facilities for drug addicts in Delhi. These facilities will free of cost treat, counsel and provide free medicines to the people who are addicted to drugs or other substances.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Addiction Treatment Market size was valued at USD 5.4 Billion in 2023 and is poised to grow from USD 5.71 Billion in 2024 to USD 8.96 Billion by 2032, growing at a CAGR of 5.80% during the forecast period (2025-2032).

Key market players operating in addiction treatment market are focusing on developing strategies to mitigate the usage of opioids along with enhancing their operations to serve the evolving needs of the consumer. Those strategies encompass acquisitions, partnerships and the opening of new facilities, aim to widen the target patient segment with expanded service offerings. Furthermore, companies are focusing on R&D to devise novel treatment approaches, including digital therapeutics, telemedicine software, and personalized care models to maximize treatment outcomes and patient adherence. In addition, a continuous focus on evidence-based practices, quality standards and patient care models will be required to prove that system is safe, effective and compliant to regulations, which will lead to a patient and stakeholder trust and loyalty.  'Alkermes plc (Ireland) ', 'Dr. Reddy’s Laboratories Ltd. (India) ', 'Hikma Pharmaceuticals plc (UK) ', 'Indivior PLC (UK) ', 'Mallinckrodt Pharmaceuticals (Ireland) ', 'Orexo AB (Sweden) ', 'Pear Therapeutics (US) Inc. (US) ', 'Pfizer Inc. (US) ', 'Viatris Inc. (US) ', 'American Addiction Centers, Inc. (US) ', 'Quest Diagnostics, Inc. (US) ', 'Sage Therapeutics, Inc. (US) ', 'Gilead Sciences, Inc. (US) ', 'Acadia Pharmaceuticals Inc. (US) ', 'Medications for Addiction Treatment (MAT) (US) ', 'Intra-Cellular Therapies, Inc. (US) ', 'Emergent BioSolutions Inc. (US) ', 'Hims & Hers Health, Inc. (US) ', 'Lundbeck A/S (Denmark) ', 'Cambrex Corporation (US) ', 'Caron Treatment Centers (US) ', 'Smart Recovery (US) ', 'Recovery Brands (US)', 'In May 2023, Camurus AB, a Swedish science-driven biopharma company, announced that Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe opioid use disorder (OUD). ', 'On May 14, 2024, Lifespan Health System announced a new addiction treatment program aiming to provide same-day assistance to patients. It's called Addiction Care Today, and it aims to provide walk-in and same-day appointments to people seeking to start treatment for substance use disorders. ', 'In February 2024, Union Council of Ministers had announced that they had launched 41 dedicated addiction treatment facilities for drug addicts in Delhi. These facilities will free of cost treat, counsel and provide free medicines to the people who are addicted to drugs or other substances.'

Advent of Digital Health Solutions: One paradigm shift that is dramatically changing the addiction treatment market are the digital health solutions launching in the addiction treatment space. The expansion of telehealth platforms, through which consultations, therapy sessions, and follow-ups can be conducted remotely, has simplified and widened access to treatment. Such technological innovation has enabled both medical professionals and patients to access real-time data from devices that monitor physiological markers of acute stress or relapse risk. 

North America is dominating with the largest addiction treatment market share. One of the main drivers contributing to the rising demand for addiction treatment services is the increasing incidence of substance use, whether that be alcohol, illicit drugs, or opioids. Nowadays, there are government programs and schemes to curb substance use and assistance to these recovering from addiction is leading to the growth of this industry as well. For instance, the USA has implemented programs like the National Opioid Action Plan. With more education, awareness, information about addiction, and treatment options, more people are obtaining assistance. Advances in medical technology and treatment methods like including medication-assisted therapy (MAT) and telehealth services are also increasing efficiency and accessibility addiction treatment in the region.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Addiction Treatment Market
Addiction Treatment Market

Report ID: SQMIG35J2121

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE